Multidrug-resistant Tuberculosis
📧 Sign up to get email alerts when something new happens for Multidrug-resistant Tuberculosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-09EMA Authorised: Dovprela (previously Pretomanid FGK) (pretomanid) — Mylan IRE Healthcare Limited
EMA authorised Dovprela (pretomanid) for multidrug-resistant tuberculosis; orphan medicine.
-
EMA approval · 2026-06-03EMA Authorised: Sirturo (bedaquiline fumarate) — Janssen-Cilag International N.V.
EMA authorises Sirturo (bedaquiline fumarate) for multidrug-resistant tuberculosis.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB [Phase 2]
Phase 2 trial evaluating the efficacy and tolerability of a five-drug regimen (bedaquiline, delamanid, levofloxacin, linezolid, and clofazim…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Training Protocol on the Natural History of Tuberculosis
Sponsored by NIAID, this ClinicalTrials.gov entry outlines a training protocol to study the natural history of tuberculosis, including laten…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR) [Phase 3]
This Phase 3 trial (FAST-MDR) in France assesses the feasibility of a new six-month treatment for multidrug-resistant tuberculosis; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-03-18EMA Authorised: Deltyba (Delamanid) — Otsuka Novel Products GmbH
The European Medicines Agency authorised Deltyba (delamanid) for treatment of multidrug-resistant tuberculosis, with Otsuka Novel Products G…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes [NA]
A clinical trial update describing a nurse case management intervention intended to improve outcomes for patients with MDR-TB and HIV co-inf…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance
The clinical trial NCT03057756 investigating treatment for multidrug-resistant tuberculosis has completed.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment [Phase 4]
Phase 4 clinical trial update investigating linezolid tolerance with dose personalization guided by therapeutic drug monitoring in the BPaL …
-
EMA approval · 2026-02-19EMA Authorised: Dovprela (previously Pretomanid FGK) (pretomanid) — Mylan IRE Healthcare Limited
The European Medicines Agency authorised Dovprela (pretomanid) for tuberculosis, including multidrug-resistant tuberculosis, with orphan med…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Bioneer Q-RFIA Clinical Evaluation
Updates the status of a clinical evaluation of the Bioneer Q-RFIA for tuberculosis, including multidrug-resistant tuberculosis, noting the s…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) [Phase 2]
This document reports a Phase 2 clinical trial (AHA-PLUS) evaluating acetohydroxamic acid in combination with a short-course regimen for mul…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets [Phase 2]
A Phase 2b clinical trial evaluating JDB0131 benzenesulfonate tablets for tuberculosis, including multidrug-resistant and rifampicin-resista…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis [Phase 2, Phase 3]
Ongoing Phase 2/Phase 3 clinical trial program evaluating stratified medicine approaches for rifampicin-resistant tuberculosis, including pu…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Endobronchial Valve in Tubercular and NTM Pulmonary Cavities. [NA]
ClinicalTrials.gov entry for a not-yet-recruiting trial evaluating endobronchial valve therapy for pulmonary cavities caused by multidrug-re…
-
EMA approval · 2025-11-24EMA Authorised: Sirturo (bedaquiline fumarate) — Janssen-Cilag International N.V.
EMA authorised Sirturo (bedaquiline fumarate) for treatment of tuberculosis, including multidrug-resistant tuberculosis. The decision date i…
-
CLINICAL_TRIALS other · 2025-09-25Clinical Trial Update: A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis
Clinical trial update on a short-course pretomanid-containing regimen for rifampicin-resistant/multidrug-resistant pulmonary tuberculosis in…
-
FDA approval · 2025-07-28FDA Approved: SIRTURO — Supplemental Application (Janssen Products, LP)
FDA approved Janssen's supplemental application for SIRTURO (bedaquiline fumarate), enabling changes to the product labeling based on new da…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients [Phase 3]
An update on a Phase 3 study evaluating oral sudapyridine (WX-081) for rifampin-resistant pulmonary tuberculosis and multidrug-resistant tub…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Triage Test for All Oral DR-TB Regimen (TRiAD Study)
A completed clinical trial update on the TRiAD study evaluating a triage diagnostic test for all-oral regimens in drug-resistant tuberculosi…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis
A completed clinical trial update examining cardiometabolic risk factors in individuals with multidrug-resistant tuberculosis.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients [Phase 3]
Phase 3 clinical study sponsored by NIAID evaluating protective strategies for household contacts exposed to newly diagnosed multidrug-resis…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults [Phase 1]
A Phase 1 trial update reports on safety, tolerability, and pharmacokinetics assessment of the TB drug candidate TBAJ-876 in healthy adults,…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: An Adaptive Randomized Controlled Trial [NA]
Columbia University sponsors an adaptive randomized controlled trial protocol that is currently recruiting. The study targets multidrug-resi…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB [Phase 1, Phase 2]
This trial update reports on the safety and tolerability of low-dose Linezolid in patients with multidrug-resistant and extensively drug-res…